1.08
                                            Precedente Chiudi:
              $1.12
            Aprire:
              $1.13
            Volume 24 ore:
                140.06K
            Relative Volume:
              0.23
            Capitalizzazione di mercato:
                $28.05M
            Reddito:
              -
            Utile/perdita netta:
              $-10.21M
            Rapporto P/E:
              -1.8487
            EPS:
                -0.5842
            Flusso di cassa netto:
                -
            1 W Prestazione:
              -5.26%
            1M Prestazione:
              -13.60%
            6M Prestazione:
                +4.85%
            1 anno Prestazione:
              -14.95%
            Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
                  
                      Neurosense Therapeutics Ltd
                    
                Settore
                  Industria
                  Telefono
                  
                      -
                    
                Indirizzo
                  
                      -
                    
                Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                NRSN
                            
                             
                        Neurosense Therapeutics Ltd 
                           | 
                    1.08 | 28.05M | 0 | -10.21M | 0 | -0.5842 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
What momentum indicators show for NeuroSense Therapeutics Ltd. stockBear Alert & Verified Swing Trading Watchlists - newser.com
Key metrics from NeuroSense Therapeutics Ltd. Equity Warrant’s quarterly dataWatch List & Verified Momentum Stock Alerts - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. Equity Warrant explainedExit Point & Expert Approved Momentum Ideas - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock outperform value peersJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
NeuroSense (NASDAQ: NRSN) sets Dec. 8, 2025 investor webinar on ALS PARAGON, Canada NOC/c - Stock Titan
Tick level data insight on NeuroSense Therapeutics Ltd. Equity Warrant volatilityWeekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com
Analyzing NeuroSense Therapeutics Ltd. Equity Warrant with multi timeframe chartsIPO Watch & Reliable Breakout Forecasts - newser.com
How moving averages guide NeuroSense Therapeutics Ltd. Equity Warrant tradingTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Can volume confirm reversal in NeuroSense Therapeutics Ltd.Earnings Risk Report & AI Driven Stock Reports - newser.com
Tools to monitor NeuroSense Therapeutics Ltd. recovery probabilityTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
How to use a screener to detect NeuroSense Therapeutics Ltd. Equity Warrant breakoutsCEO Change & Safe Capital Preservation Plans - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock attract more institutional investorsJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Using Ichimoku Cloud for NeuroSense Therapeutics Ltd. Equity Warrant technicalsProfit Target & Consistent Return Investment Signals - newser.com
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualizedQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
How institutional ownership impacts NeuroSense Therapeutics Ltd. stockJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
What downside risks could hit NeuroSense Therapeutics Ltd. (H1Z) stockMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Signal strength of NeuroSense Therapeutics Ltd. stock in tech scannersVolume Spike & Weekly Watchlist of Top Performers - newser.com
Key metrics from NeuroSense Therapeutics Ltd.’s quarterly data2025 Retail Activity & Long-Term Safe Investment Plans - newser.com
Is NeuroSense Therapeutics Ltd. stock a safe haven assetJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Can NeuroSense Therapeutics Ltd. hit a new high this month2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecastingQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Visual analytics tools that track NeuroSense Therapeutics Ltd. performanceQuarterly Growth Report & Verified Swing Trading Watchlist - newser.com
Tools to monitor NeuroSense Therapeutics Ltd. Equity Warrant recovery probability2025 Pullback Review & AI Driven Stock Reports - newser.com
Multi factor analysis applied to NeuroSense Therapeutics Ltd. Equity WarrantJuly 2025 Institutional & Safe Investment Capital Preservation Plans - newser.com
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflation2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Using RSI to spot recovery in NeuroSense Therapeutics Ltd.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Visualizing NeuroSense Therapeutics Ltd. stock with heatmapsJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Using data tools to time your NeuroSense Therapeutics Ltd. Equity Warrant exitJuly 2025 Breakouts & Weekly Watchlist of Top Performers - newser.com
Is NeuroSense Therapeutics Ltd. showing signs of accumulation2025 Analyst Calls & Safe Entry Point Alerts - newser.com
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in high volatility marketsEarnings Growth Report & Verified Technical Signals - newser.com
What sentiment indicators say about NeuroSense Therapeutics Ltd. stockPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):